Biotech grants in Belgium

Closed

Funds Brussels companies developing their first technologically innovative prototype or service, covering 50 to 70 percent of the budget for technical and economic validation.

Closed

Funds Brussels companies doing industrial research, experimental development, or process innovation through grants covering 15 to 70 percent of project costs.

Discontinued

Invests in Walloon industrial, healthcare, and technology companies with minority equity for scale and strategic development.

Open

Supports translating decades of ageing biology into biotech or pharma proofs-of-concept that prevent, delay or revert age-related disease.

Open

Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.

Open

Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.

Open

Funds strategic deep-tech challenge projects in materials, energy, biotechnology, and climate innovation.

Open

Connects research teams and institutions for Interregional Innovation Investments Strand in manufacturing, materials science, and agriculture innovation.

Open

Funds EISMEA Interregional Innovation Investments for small and medium-sized enterprises in developing European regions through cross-border transfer and capability building.

Open

Funds European doctoral networks enabling multi-country training in life and engineering sciences.

Open

Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.

Open

Supports small and medium firms in early-stage deep technologies through public proposals and commercialization mentoring.

Open

Funds researchers 5 to 15 years past their PhD who are building an independent research team in Europe through an ERC Consolidator Grant.

Open

Funds healthcare programs building resilience and prevention in cancer, rare diseases, and cardiovascular health.

Open

Offers open access collaboration through Eureka Network Projects so small enterprises can join international innovation groups.

Open

Supports internationally mobile postdoctoral researchers placed in Israeli institutions to build independent research careers through EU mobility fellowships.

Scheduled

Funds two €6.4M projects that turn soil-friendly biotechnology into scalable, safe and market-ready farm solutions.

Scheduled

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

Scheduled

Funds climate-health exposome research linking lifelong exposures, disease burden, vulnerability and resilience.

Scheduled

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

Scheduled

Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.

Scheduled

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

Scheduled

Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.

Scheduled

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.